TMC Life Sciences Bhd (XKLS:0101) Operating Income: RM22.3 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0101 TMC Life Sciences Bhd XKLS:0101
60 GF Score
Price RM0.47
GF Value RM0.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd Operating Income?

TMC Life Sciences Bhd XKLS:0101 60 Operating Income is RM22.3 Mil as of Mar. 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 60/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review.

TMC Life Sciences Bhd's Operating Income for the three months ended in Mar. 2026 was RM3.8 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was RM22.3 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. TMC Life Sciences Bhd's Operating Income for the three months ended in Mar. 2026 was RM3.8 Mil. TMC Life Sciences Bhd's Revenue for the three months ended in Mar. 2026 was RM89.7 Mil. Therefore, TMC Life Sciences Bhd's Operating Margin % for the quarter that ended in Mar. 2026 was 4.27%.

Warning Sign:

TMC Life Sciences Bhd operating margin has been in a 5-year decline. The average rate of decline per year is -22.5%.

TMC Life Sciences Bhd's 5-Year average Growth Rate for Operating Margin % was -22.50% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. TMC Life Sciences Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was 1.02%. TMC Life Sciences Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.47%.

TMC Life Sciences Bhd  (XKLS:0101) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

TMC Life Sciences Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=15.308 * ( 1 - 36.05% )/( (964.837 + 962.124)/ 2 )
=9.789466/963.4805
=1.02 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1119.148 - 60.557 - ( 112.896 - max(0, 107.828 - 201.582+112.896))
=964.837

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1110.002 - 59.625 - ( 118.116 - max(0, 107.114 - 195.367+118.116))
=962.124

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

TMC Life Sciences Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=18.22/( ( (716.29 + max(27.602, 0)) + (715.103 + max(17.073, 0)) )/ 2 )
=18.22/( ( 743.892 + 732.176 )/ 2 )
=18.22/738.034
=2.47 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(64.053 + 17.634 + 6.999) - (60.557 + 0 + 0.527)
=27.602

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(57.869 + 18.638 + 0.744) - (59.625 + 0 + 0.553)
=17.073

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

TMC Life Sciences Bhd's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=3.827/89.701
=4.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

TMC Life Sciences Bhd Operating Income Related Terms

TMC Life Sciences Bhd Operating Income Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd Operating Income Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.86 30.08 42.95 53.25 7.64

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.54 -0.02 7.94 10.53 3.83
XKLS:0101
60GF Score
TMC Life Sciences Bhd XKLS:0101
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM22.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of RM22.3 Mil mean?
TMC Life Sciences Bhd (XKLS:0101) has a Operating Income of RM22.3 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on TMC Life Sciences Bhd and its competitors.
Is TMC Life Sciences Bhd's Operating Income too high?
TMC Life Sciences Bhd's current Operating Income is RM22.3 Mil. Overall, TMC Life Sciences Bhd has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Operating Income compare to HCA and THC?
TMC Life Sciences Bhd's Operating Income of RM22.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Healthcare Providers & Services company?
A good Operating Income depends on the Healthcare Providers & Services industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on TMC Life Sciences Bhd and its competitors. TMC Life Sciences Bhd's current Operating Income is RM22.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.47 — trading 24.2% below its estimated fair value. The current Operating Income is RM22.3 Mil. TMC Life Sciences Bhd's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Operating Income is RM22.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.47 is trading 24.2% below its estimated GF Value™ of RM0.62. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • Operating Income: RM22.3 Mil
  • GF Value™: RM0.62 vs. price of RM0.47 (24.2% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
60GF Score

Get the complete analysis for XKLS:0101

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.47
Price
RM0.62
GF Value